Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer by Mountzios, G., Samantas, E., Senghas, K., Zervas, E., Krisam, J., Samitas, K., Bozorgmehr, F., Kuon, J., Agelaki, S., Baka, S., Athanasiadis, I., Gaissmaier, L., Elshiaty, M., Daniello, L., Christopoulou, A., Pentheroudakis, G., Lianos, E., Linardou, H., Kriegsmann, K., Kosmidis, P., El Shafie, R., Kriegsmann, M., Psyrri, A., Andreadis, C., Fountzilas, E., Heussel, C.-P., Herth, F.J., Winter, H., Emmanouilides, C., Oikonomopoulos, G., Meister, M., Muley, T., Bischoff, H., Saridaki, Z., Razis, E., Perdikouri, E.-I., Stenzinger, A., Boukovinas, I., Reck, M., Syrigos, K., Thomas, M., Christopoulos, P.

Get full text

Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer by El Shafie, R.A., Seidensaal, K., Bozorgmehr, F., Kazdal, D., Eichkorn, T., Elshiaty, M., Weber, D., Allgäuer, M., König, L., Lang, K., Forster, T., Arians, N., Rieken, S., Heussel, C.-P., Herth, F.J., Thomas, M., Stenzinger, A., Debus, J., Christopoulos, P.

Get full text

EP08.01-072 Clinical Value of Patras Immunotherapy Score (PIOS) Formula in Patients With Advanced NSCLC Treated With Immunotherapy/Chemotherapy by Dimitrakopoulos, F.-I., Christopoulos, P., Elshiaty, M., Daniello, L., Pyrousis, I., Kottorou, A., Makatsoris, T., Kalofonos, H., Koutras, A.

Get full text

67P Blood cell gene expression and clinical characteristics in advanced non-small cell lung cancer with immune-related adverse events by Daniello, L., Elshiaty, M., Lusky, F., Blasi, M., Schneider, M.A., Bozorgmehr, F., Shah, R., Kazdal, D., Angeles, A., Liersch, S., Eichhorn, F., Allgäuer, M., Janke, F., Bischoff, H., Thomas, M., Sültmann, H., Stenzinger, A., Christopoulos, P.

Get full text

EP08.01-031 Blood Gene Expression Changes in Metastatic Lung Cancer under second-line Immunotherapy according to Clinical Response by Lusky, F., Schindler, H., Elshiaty, M., Gaissmaier, L., Daniello, L., Bozorgmehr, F., Kuon, J., Shah, R., Schneider, M.A., Eichhorn, F., Trudzinski, F., Angeles, A., Janke, F., Kirchner, M., Kazdal, D., Stenzinger, A., Sültmann, H., Thomas, M., Christopoulos, P.

Get full text

P75.04 Advanced Lung Cancer Inflammation Index (ALI), Neutrophil-to-Lymphocyte Ratio (NLR), and PD-(L)1 Inhibitor Efficacy in NSCLC by Mountzios, G., Samantas, E., Senghas, K., Zervas, E., Krisam, J., Samitas, K., Bozorgmehr, F., Kuon, J., Agelaki, S., Baka, S., Athanasiadis, I., Gaissmaier, L., Elshiaty, M., Daniello, L., Christopoulou, A., Pentheroudakis, G., Lianos, E., Linardou, H., Kriegsmann, K., Kosmidis, P., El Shafie, R., Kriegsmann, M., Psyrri, A., Andreadis, C., Fountzilas, E., Heussel, C., Herth, F., Winter, H., Emmanouilidis, C., Oikonomopoulos, G., Meister, M., Muley, T., Bischoff, H., Saridaki, Z., Razis, E., Perdikouri, E., Stenzinger, A., Boukovinas, I., Reck, M., Syrigos, K., Thomas, M., Christopoulos, P.

Get full text